What i understand from the annual report is that there will be-
a 5 million placement to a unknown party.
3 million rights issue.
7.5 million via C2 ventures
CardieX is currently underway with multiple funding initiatives for raising capital, including a placement of approximately A$5m, expected to be completed in November 2023,
followed by a A$3m rights issue expected to be completed in December 2023.
• C2 Ventures Pty Ltd, a Company jointly owned by Directors Mr Niall Cairns and Mr Craig Cooper, has entered into a funding agreement with CardieX to provide total capital of A$7,500,000, including a A$1.5m facility limit to be received during the December 2023 quarter, followed by a further A$6m facility limit to be provided during the 2024 calendar year.
CDX Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
